Newborn Screening for Methylmalonic Aciduria by Tandem Mass Spectrometry: 7 Years' Experience From Two Centers in Taiwan

Received 12 January 2010; accepted 26 February 2010.

Background

The clinical course of methylmalonic aciduria (MMA) is fulminant in neonates and emergency management is necessary to save lives. It is therefore very important to differentiate affected from unaffected neonates immediately when there are abnormal results regarding MMA in newborn screening.

Methods

Between January 2002 and December 2008, 598,522 newborns were screened for MMA by 2 neonatal screening centers: the Chinese Foundation of Health and the Taipei Institute of Pathology. A total of 22 newborns were referred to confirmatory medical centers, and 7 were confirmed as having MMA. The initial propionylcarnitine (C3) level, C3/acetylcarnitine (C2) ratio, plasma ammonia, liver function tests, blood pH and bicarbonate were compared between the true-positive and false-positive groups.

Results

The C3/C2 ratio and plasma ammonia were markedly higher in the true-positive MMA group (p < 0.0001). Blood gas pH (p = 0.029), bicarbonate (p = 0.019), and aspartate aminotransferase (p = 0.005) also significantly differed between these 2 groups.

Conclusion

Referred newborns with elevated plasma C3/C2 ratios > 0.4 or ammonia levels > 200 mg/dL should be highly suspected of having MMA.

Key Words: methylmalonic aciduria , newborn screening , Taiwan , tandem mass spectrometry

No full text is available. To read the body of this article, please view the PDF online.

Article Outline

• Abstract

• References

• Copyright

References

1. 1 Zwickler T, Lindner M, Aydin HI, Baumgartner MR, Bodamer OA, Burlina AB, et al Diagnostic work-up and management of patients with isolated methylmalonic acidurias in European metabolic centres . J Inherit Metab Dis . 2008;31:361–367 . CrossRef

2. 2 Acquaviva C , Benoist JF , Pereira S . Molecular basis of methylmalonyl-CoA mutase apoenzyme defect in 40 European patients affected by mut0 and mut− forms of methylmalonic acidemia: identification of 29 novel mutations in the MUT gene . Hum Mutat . 2005;25:167–176 . CrossRef

3. 3 Kavita K , Behrouz R . Inherited metabolic disorders and cerebral infarction . Expert Rev Neurother . 2008;8:1731–1741 . CrossRef

4. 4 Tanpaiboon P . Methylmalonic acidemia (MMA) . Mol Genet Metab . 2005;85:2–6 . MEDLINE | CrossRef

5. 5 Cosson MA, Benoist JF, Touati G, Déchaux M, Royer N, Grandin L, et al Long-term outcome in methylmalonic aciduria: a series of 30 French patients . Mol Genet Metab . 2009;97:172–178 . CrossRef

6. 6 Lee NC, Chien YH, Peng SF, Huang AC, Liu TT, Ariel SH Wu, et al Brain damage by mild metabolic derangements in methylmalonic acidemia . Pediatr Neurol . 2008;39:325–329 . Abstract | Full Text | Full-Text PDF (650 KB) | CrossRef

7. 7 Shigematsu Y, Hirano S, Hata I, Yukie T, Masakatsu S, Nobuo S, et al Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan . J Chromatogr B . 2002;776:39–48 .

8. 8 Schulze A , Lindner M , Kohlmuller D , Olgemöller K , Mayatepek E , Hoffmann G . Expanded neonatal screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications . Pediatrics . 2003;111:1399–1406 .

9. 9 Chace DH , Kalas TA , Naylor EW . Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns . Clin Chem . 2003;49:1797–1817 . MEDLINE | CrossRef

10. 10 Wilcken B , Wiley V , Hammond J , Carpenter K . Screening newborns for inborn errors of metabolism by tandem mass spectrometry . N Engl J Med . 2003;348:2304–2312 . CrossRef

11. 11 Ia Marca G , Malvagia S , Pasquini E , Innocenti M , Donati MA , Zammarchi E . Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry . Clin Chem . 2007;53:1364–1369 . CrossRef

12. 12 Coude FX , Sweetman L , Nyhan WL . Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria: a possible explanation for hyperammonemia in propionic and methylmalonic aciduria . J Clin Invest . 1979;64:1544–1551 . MEDLINE | CrossRef

a Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.

b Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.

c Institute of Genetics, School of Life Sciences, Taipei, Taiwan, R.O.C.

d VYM Genome Research Center, Taipei, Taiwan, R.O.C.

e Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.

f Department of Pediatrics, Far Eastern Memorial Hospital, Taipei, Taiwan, R.O.C.

g Department of Pediatrics, Renai Branch, Taipei City Hospital, Taipei, Taiwan, R.O.C.

h Department of Pediatrics, Mackay Memorial Hospital, Taipei, Taiwan, R.O.C.

i Neonatal Screening Center, Chinese Foundation of Health, Taipei, Taiwan, R.O.C.

j Section of Newborn Screening, Taipei Institute of Pathology, Taipei, Taiwan, R.O.C.

k Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan, R.O.C.

l Department of Pediatrics, Chang Gung Children's Hospital, Taoyuan, Taiwan, R.O.C.

m Association of Congenital and Inherited Metabolic Disease, Taipei, Taiwan, R.O.C.

Correspondence to: Dr Dau-Ming Niu, Department of Pediatrics, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan, R.O.C.

† Kang-Hsiang Cheng and Mei-Ying Liu contributed equally to this work.

PII: S1726-4901(10)70067-8

doi:10.1016/S1726-4901(10)70067-8

6 of 13